Projected top 10 drugmakers in 2024

Big Pharma is expected to get much bigger over the next several years, with the companies competing to grow their sales in a list of established and emerging therapeutic areas, notably cancer and immunology.

As reported by EvaluatePharm, the top 10 drugmakers in 2024 will hold 35% of the total biopharma market share contributing to more than $420 billion in sales that year. 

The top 5 drugmakers are expected to be Novartis followed by Pfizer, Roche, Johnson & Johnson and Sanofi.

Click here to see who the remaining five companies.